Ruolan Li
Impact in
-
- Traditional Chinese Medicine Analysis
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Traditional Chinese Medicine Analysis 4
- Medicinal Plants and Neuroprotection 4
- Co-authors
- Chunjie Wu (26 shared papers)Wei Peng (23 shared papers)Qing Zhang (18 shared papers)Huxinyue Duan (14 shared papers)Jia Liu (11 shared papers)Shujun Wei (7 shared papers)Yongxiang Gao (8 shared papers)Dan Wang (1 shared paper)
- Journals
- Frontiers in Pharmacology (9 papers)Pharmacological Research (3 papers)Poultry Science (2 papers)RSC Advances (2 papers)Journal of Ethnopharmacology (2 papers)
- Partner nations
- ChinaUnited StatesMyanmar
In The Last Decade
Ruolan Li
65 papers receiving 2.1k citations
Ruolan Li's Hit Papers
Peers
Comparison fields: 5 of 142
- Complementary and alternative medicine 219
- Pharmacology 209
- Biochemistry 82
- Cancer Research 173
- Molecular Biology 789
Countries citing papers authored by Ruolan Li
This map shows the geographic impact of Ruolan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolan Li more than expected).
Fields of papers citing papers by Ruolan Li
This network shows the impact of papers produced by Ruolan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolan Li. The network helps show where Ruolan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruolan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress Hit paper breakdown → | 2021 | 649 |
| 2 | 2021 | 200 | |
| 3 | 2019 | 130 | |
| 4 | 2019 | 95 | |
| 5 | 2019 | 63 | |
| 6 | 2019 | 57 | |
| 7 | 2023 | 52 | |
| 8 | 2021 | 47 | |
| 9 | 2023 | 46 | |
| 10 | 2020 | 41 | |
| 11 | 2020 | 39 | |
| 12 | 2022 | 36 | |
| 13 | 2020 | 30 | |
| 14 | 2022 | 29 | |
| 15 | 2020 | 28 | |
| 16 | 2019 | 26 | |
| 17 | Development and in vivo Evaluation of Hydroxy-α-Sanshool Intranasal Liposomes as a Potential Remedial Treatment for Alzheimer’s Disease | 2022 | 26 |
| 18 | 2017 | 24 | |
| 19 | 2022 | 24 | |
| 20 | 2022 | 24 |
About Ruolan Li
Ruolan Li is a scholar working on Complementary and alternative medicine, Pharmacology, Molecular Biology, Immunology and Cancer Research, having authored 72 papers that have together received 2.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (4 papers), Traditional Chinese Medicine Analysis (4 papers), Medicinal Plants and Neuroprotection (4 papers), Plant chemical constituents analysis (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Chromatography in Natural Products (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Complementary and alternative medicine (219 citations), Pharmacology (209 citations), Biochemistry (82 citations), Cancer Research (173 citations) and Molecular Biology (789 citations). Ruolan Li has collaborated with scholars based in China, United States and Myanmar. Frequent co-authors include Chunjie Wu, Wei Peng, Qing Zhang, Huxinyue Duan, Jia Liu, Shujun Wei, Yongxiang Gao, Dan Wang, Jia Liu and Ling‐Yu Wang. Their work appears in journals such as Frontiers in Pharmacology, Pharmacological Research, Poultry Science, RSC Advances and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.